CPT Capital

Mycoprotein producer Enough raises €40M toward doubling its production capacity

Now with the Netherlands factory online, Enough is ramping up to produce over a tonne of Abunda every hour and around 10,000 metric tonnes per year. 

Synthesis Capital closed its first fund with $300M, giving boost to food tech’s future

While much of the recent capital has targeted the consumer-facing, or downstream side, the firm believes future investments will go into technologies closer to the farm or lab.

UPSIDE Foods bites into $400M round to serve cultivated meat later this year

Pending regulatory review, the company’s chicken product will be available to consumers in the U.S. later this year.

New Culture lands $25 million to commercialize its cheesy, animal-free mozzarella

Led by sales of cheddar and mozzarella, the U.S. cheese market alone was valued at $34.3 billion in 2019, and is projected to reach $45.5 billion by 2027, growing at a compound annual growth rate of 5

Biotech startup Shiru sprouting plant-based ingredients with new capital infusion

The company plans to have ingredients ready by next year, which means we could see the first commercial products containing Shiru’s ingredients on grocery store shelves as early as 2023.